Parkwood LLC’s Fortress Biotech FBIO Stock Holding History

Parkwood LLC’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-3,781	Closed	-$149K	–	255
2013 Q4	$149K	Buy	+3,781	New	+$146K	0.04%	305

Other funds holding FBIO

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACM

Advent Capital Management New York $4.46B AUM 0.73% 1-Year Est. Return

Parkwood LLC's FBIO Position: Q1 2014 in Review

Parkwood LLC sold out of Fortress Biotech (FBIO) in Q1 2014, closing a stake of 3,781 shares — an estimated $149K sold.

Parkwood LLC first reported a position in FBIO in Q4 2013 and held it in 1 quarter. The position peaked at $149K in Q4 2013. 57 funds tracked by Wall St. Rank hold FBIO as of Q1 2014.

Parkwood LLC reported no remaining Fortress Biotech position as of Q1 2014 after selling out during the quarter.
Parkwood LLC sold 3,781 Fortress Biotech shares in Q1 2014, an estimated $149K.
Parkwood LLC first reported a position in Fortress Biotech in Q4 2013 and held it in 1 quarter.
Parkwood LLC's Fortress Biotech position peaked at $149K in Q4 2013.
57 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2014.

Based on Parkwood LLC's 13F filing for Q1 2014, filed 9 May 2014.